Gamechanger: Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in MINOCA

HomeCirculation: Cardiovascular ImagingVol. 16, No. 8Gamechanger: Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in MINOCA No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextGamechanger: Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in MINOCA Erik B. Schelbert and Yaron Fridman Erik B. SchelbertErik B. Schelbert Correspondence to: Erik Schelbert, MD, MS, Cardiovascular Magnetic Resonance at United Hospital, Allina Health Minneapolis Heart Institute at United Hospital, 225 Smith Ave N, Ste. 400, St. Paul, MN 55102-2568. Email E-mail Address: [email protected] https://orcid.org/0000-0003-0356-4437 Allina Health Minneapolis Heart Institute at United Hospital, Saint Paul, MN (E.B.S.). Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN (E.B.S.). Search for more papers by this author and Yaron FridmanYaron Fridman Asheville Cardiology Associates, NC (Y.F.). Search for more papers by this author Originally published15 Aug 2023https://doi.org/10.1161/CIRCIMAGING.123.015833Circulation: Cardiovascular Imaging. 2023;16This article is a commentary on the followingPrognostic Value of Cardiac Magnetic Resonance Imaging in Patients With a Working Diagnosis of MINOCA—An Outcome Study With up to 10 Years of Follow-Up"Gamechanger: Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in MINOCA." Circulation: Cardiovascular Imaging, 16(8), pp. e015833FootnotesFor Disclosures, see page 644.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Erik Schelbert, MD, MS, Cardiovascular Magnetic Resonance at United Hospital, Allina Health Minneapolis Heart Institute at United Hospital, 225 Smith Ave N, Ste. 400, St. Paul, MN 55102-2568. Email erik.schelbert@allina.comREFERENCES1. Yogi Berra Quotes. (n.d.). BrainyQuote.com. Retrieved July 8, from BrainyQuote.com Web site: https://www.brainyquote.com/quotes/yogi_berra_125285.Google Scholar2. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.Circulation. 1999; 100:1992–2002. doi: 10.1161/01.cir.100.19.1992LinkGoogle Scholar3. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation. 1977; 56:786–794. doi: 10.1161/01.cir.56.5.786LinkGoogle Scholar4. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.N Engl J Med. 2000; 343:1445–1453. doi: 10.1056/NEJM200011163432003CrossrefMedlineGoogle Scholar5. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, Neubauer S. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.Circulation. 2004; 110:1535–1541. doi: 10.1161/01.CIR.0000142045.22628.74LinkGoogle Scholar6. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM; Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.Circulation. 2008; 117:629–637. doi: 10.1161/CIRCULATIONAHA.107.723262LinkGoogle Scholar7. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.JAMA. 2012; 308:890–896. doi: 10.1001/2012.jama.11089CrossrefMedlineGoogle Scholar8. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schuler WO, Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease.AJR Am J Roentgenol. 2005; 184:1420–1426. doi: 10.2214/ajr.184.5.01841420CrossrefMedlineGoogle Scholar9. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.Circulation. 2001; 103:2780–2783. doi: 10.1161/hc2301.092121LinkGoogle Scholar10. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Eur Heart J. 2005; 26:1461–1474. doi: 10.1093/eurheartj/ehi258CrossrefMedlineGoogle Scholar11. Konst RE, Parker M, Bhatti L, Kaolawanich Y, Alenezi F, Elias-Smale SE, Nijveldt R, Kim RJ. The prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA ― An outcome study with up to 10 years of follow-up.Circ Cardiovasc Imaging. 2023; 16:e014454. doi: 10.1161/CIRCIMAGING.122.014454LinkGoogle Scholar12. Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A, Cushman M, Kumbhani DJ, Arslanian-Engoren C, et al; American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a Scientific Statement From the American Heart Association.Circulation. 2019; 139:e891–e908. doi: 10.1161/CIR.0000000000000670LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesPrognostic Value of Cardiac Magnetic Resonance Imaging in Patients With a Working Diagnosis of MINOCA—An Outcome Study With up to 10 Years of Follow-UpRegina E. Konst, et al. Circulation: Cardiovascular Imaging. 2023;16 August 2023Vol 16, Issue 8 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCIMAGING.123.015833PMID: 37582158 Originally publishedAugust 15, 2023 KeywordsEditorialsmagnetic resonance imagingmyocarditisprognosistroponinPDF download Advertisement SubjectsImagingMagnetic Resonance Imaging (MRI)Prognosis